
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+2
ANGANY is an emerging, private pharmaceutical company, based in Quebec City, Canada. ANGANY has tackled the specific challenges of allergy to invent first-in class pharmaceuticals. ANGANY has developed an exclusive vaccine platform based on synthetic biology: the eBioparticle TM self-adjuvant vector. ANGANY also produces high quality, high purity allergens for diagnostic purposes. Finally, ANGANY has developed a flexible, fast and highly scalable 3rd generation plant production platform. ANGANYs vaccine approach opens the door to applications in cancer, infectious, autoimmune diseases and others. ANGANY is a Franco-Canadian collaboration led by Louis-Philippe Vezina, a renowned pharmaceutical entrepreneur
Allergenes recombinants,immunotherapy,biotechnology,innovation,allergy,allergens,and therapeutics
Angany operates in the Pharmaceutical manufacturing industry.
Angany's revenue is 11m - 100m
Angany has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.